Trial · NCT03407625
Outcomes24
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 24
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Participants With Vaginal Delivery | at delivery | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Time to Delivery | from start of induction agent to time of delivery | This number represents women delivered at first induction | hours | MEAN |
| SECONDARY | Indication for Cesarean Delivery | at delivery | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Dose of Oxytocin Given (mcg or mg) | at delivery | Total dose of oxytocin was not found to be meaningful, thus data were not collected. | ||
| SECONDARY | Time With Foley Bulb in Place | From time of documented insertion until the time of documented expulsion or removal, whichever came first, assessed up to 24 hours. | Number of women with successful Foley bulb placement | hours | MEDIAN |
| SECONDARY | Presence of Chorioamnionitis | at delivery | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Use of Intravenous Analgesia During Labor | at delivery | Intravenous analgesia was not clinically meaningful and was not collected | ||
| SECONDARY | Number of Participants Used Neuraxial Analgesia During Labor | from start of induction to delivery | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants Used General Anesthesia for Delivery | at delivery | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants With Meconium-stained Amniotic Fluid | At the time of rupture of membranes and at delivery | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Terbutaline Use | at delivery | Terbutaline use was not felt to be clinically meaningful, and thus data were not collected | ||
| SECONDARY | Number of Participants With Tachysystole | at delivery | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants With Uterine Hyperstimulation Syndrome | at delivery | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants With Excess Blood Loss | at delivery | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants With Blood Transfusion | at delivery | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants With Uterine Rupture | at delivery | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants With Unplanned Hysterectomy | at discharge from the hospital following delivery | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants With Postpartum Fever | Following delivery and prior to discharge | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants With Umbilical Cord Blood pH <7.0 | at delivery | This number represents available umbilical cord blood gas | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With an 5-minute Apgar Score Less Than 4 | 5 minutes after time of birth | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03407625/outcomes